Skip to main navigation
  • About Us
    • Senior Management
    • Board of Directors
    • Contact Us
  • Pipeline
    • Lorigerlimab (PD-1 × CTLA-4)
    • MGC026 (B7-H3 ADC)
    • MGC028 (ADAM9 ADC)
    • MGD024 (CD123 × CD3)
    • MGC030
  • Technology
    • Platforms
    • Publications
  • Patients
    • Clinical Trials
    • Expanded Access
    • Resources
  • Investors

    Investor Relations

    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Senior Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
      • Charters and Documents
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
      • Key Metrics
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
      • Ownership Profile
    • Investor FAQs
    • Publications
    • Contact Investor Relations
  • Join Our Team
    • Current Openings
    • Employee Benefits

SEC Filing Details

Shareholder Tools


  • Facebook
  • LinkedIn
  • Twitter
  • RSS

Breadcrumb

Home Investors S-8

SEC Filing Details

Document Details

Form
S-8
Filing Date
Sep 3, 2026
Document Date
Sep 3, 2026
Form Description
Securities offered to employees pursuant to employee benefit plans
Filing Group
Registration Statements
Company
MacroGenics, Inc.
Issuer
MACROGENICS INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
XML - XBRL INSTANCE DOCUMENT
©2026 MacroGenics, Inc.
  • Contact Us
  • Site Map
  • Privacy Policy
  • Terms of Use
  • Other Notices